Click a link below to view the mailing archive as if it had been sent to you.
| 2016-01-30 12:15 | | Presidential Candidates & Rx Policy and more... |
| 2016-01-30 00:15 | | Genentech snags a PhII-ready IL-33 asthma/COPD drug from Amgen and more... |
| 2016-01-29 12:15 | | Allergan links with AstraZeneca on new antibiotic treatment and more... |
| 2016-01-29 00:15 | | A Bad Day for Biotech as Celgene, Incyte Tumble and more... |
| 2016-01-28 12:15 | | Is Another Big Transformation on the Way for GlaxoSmithKline? and more... |
| 2016-01-28 00:15 | | Bristol-Myers Squibb (BMY) Closed Down as Analysts Expect Earnings Decline and more... |
| 2016-01-27 12:15 | | Lilly and Roche Diagnostics to Collaborate on Alzheimer's Disease Adjunct Diagnostic Tool and more... |
| 2016-01-27 00:15 | | Why the FDA shouldn’t bow to parental pressure over Duchenne drug and more... |
| 2016-01-26 12:15 | | Will 2016 Be Vertex's Best Year Yet? and more... |
| 2016-01-26 00:15 | | BMS' Opdivo evens the score in melanoma with two new FDA green lights and more... |
| 2016-01-25 12:15 | | Aiming for $250M in sales, Horizon quadruples force behind gout med Krystexxa and more... |
| 2016-01-25 00:15 | | Big Earnings Expectations For Big Biotech and more... |
| 2016-01-24 00:15 | | Gilead Takes a Page Out of Celgene's Playbook |
| 2016-01-23 12:15 | | Yes, Gilead put superhigh prices on hep C drugs, but what can you do? Senators ask and more... |
| 2016-01-23 00:15 | | Forbes: There Is 'A Bit' Of Hope For Sarepta Therapeutics and more... |
| 2016-01-22 12:15 | | Astellas Extends Tender Offer to Acquire All Outstanding Shares of Ocata Therapeutics and more... |
| 2016-01-22 00:15 | | Bristol-Myers' Opdivo Gets Nod for Melanoma From U.K. Regulator and more... |
| 2016-01-21 12:15 | | Glaxo weighs Qualcomm JV in quest to move 'beyond the pill' and more... |
| 2016-01-21 00:15 | | Biotech with deficit, layoffs awards CEO $1 million severance package and more... |
| 2016-01-20 12:15 | | Abbott Laboratories’ 4Q15 Revenues Expected to Fall and more... |
| 2016-01-20 00:15 | | Ipsen to Step Up Deal-Making, Scout for New Cancer Products and more... |
| 2016-01-19 12:15 | | Novartis' psoriasis mega-blockbuster hopeful Cosentyx nabs 2 new indications and more... |
| 2016-01-19 00:15 | | Patent Expirations Of Crestor And Zetia And The Impact On Other Cholesterol Drugs and more... |
| 2016-01-18 00:15 | | AbbVie's Management Just Made Some Pretty Bold Predictions and more... |
| 2016-01-17 00:15 | | 4 Top BioPharma Movers of the Past Week |
| 2016-01-16 12:15 | | Biotech Investing: This Is Undoubtedly the Craziest Stat You'll Ever See and more... |
| 2016-01-16 00:15 | | French drug trial suspended after participant left brain dead, five others critically ill and more... |
| 2016-01-15 12:15 | | Boston Scientific smuggled counterfeit resin for pelvic mesh, racketeering lawsuit alleges and more... |
| 2016-01-15 00:15 | | Howard Schiller made his first public appearance as Valeant’s interim CEO at JP Morgan Healthcare Conference on Wednesday and more... |
| 2016-01-14 12:15 | | J&J CEO Prefers Smaller Acquisitions Even as Cash Pile Grows and more... |
| 2016-01-14 00:15 | | Pfizer CEO: Allergan deal is 'a lot more about growth' than job cuts and more... |
| 2016-01-13 12:15 | | Shire's Baxalta Acquisition: An Orphan Drugs Market Dream? and more... |
| 2016-01-13 00:15 | | Roche and AbbVie line up for quick approval for cancer drug venetoclax and more... |
| 2016-01-12 12:15 | | What Investors Can Learn from MannKind Corporation's Afrezza Fiasco and more... |
| 2016-01-12 00:15 | | Anavex Soars on Positive Alzheimer’s Results and more... |
| 2016-01-11 12:15 | | 4 Companies Pfizer Just Increased Its Stake In and more... |
| 2016-01-11 00:15 | | Theravance Inc. Stock Was Up 14% in December -- Here's Why and more... |
| 2016-01-09 12:15 | | 5 Biotech Predictions for 2016 and more... |
| 2016-01-09 00:15 | | Interim Valeant CEO Schiller expects to stick to the script--and that means being 'boring' in 2016 and more... |
| 2016-01-08 12:15 | | 3 key biopharma manufacturing stories to keep an eye on in 2016 and more... |
| 2016-01-08 00:15 | | Martin Shkreli uses $45M E*Trade acct for criminal bond and more... |
| 2016-01-07 12:15 | | Could an old Roche arthritis med become a pioneering PAH treatment? and more... |
| 2016-01-07 00:15 | | Gilead Ends a Phase 2 Study for Antibody and more... |
| 2016-01-06 12:15 | | Gilead grabs priority review for pangenotype hep C combo; Hep B med shown to be safe and more... |
| 2016-01-06 00:15 | | Valeant to replace hospitalized CEO Pearson: WSJ and more... |
| 2016-01-05 12:15 | | Baxalta strikes a $1.6B immuno-oncology deal ahead of potential Shire deal and more... |
| 2016-01-05 00:15 | | Novartis agrees to settle sex discrimination suit for $8M and more... |
| 2016-01-04 12:15 | | To Discover Better Drugs Faster, MD Anderson Is Innovating How It Innovates and more... |
| 2016-01-04 00:15 | | What Does 2016 Hold for Biotech Stocks? and more... |
| 2016-01-02 12:15 | | The Top 5 Best Performing Biotech Stocks of 2015 and more... |
| 2016-01-02 00:15 | | Will 2016 Be Johnson & Johnson's Best Year Yet? and more... |
| 2016-01-01 12:15 | | This Lung Cancer Drug May Not Be What It Seems, Chemists Say and more... |
